CKD Prediction in HIV+ Patients

Reference point score on equation card

Predicts the 5‑year risk of chronic kidney disease in HIV‑positive adults using the validated D:A:D cohort risk score based on demographic, clinical, and HIV‑related factors 1.

Age
19-39 years040-49 years+250-59 years+460-90 years+6
Glucose > 140 mg/dL (7.77 mmol/L)
No0Yes+2
Systolic BP > 140 mmHg
No0Yes+2
Hypertension
No0Yes+2
Triglycerides > 200 mg/dL (> 2.26 mmol/L)
No0Yes+1
Proteinuria
No0Yes+2
CD4+ < 200 cell/µL
No0Yes+1

Indications for Use

Used in HIV‑positive adults with baseline eGFR > 60 mL/min/1.73 m² to estimate 5‑year CKD risk and guide antiretroviral selection, especially when considering nephrotoxic agents. Identifies patients at low, medium, or high CKD risk based on validated D:A:D cohort data (17,954 participants; CKD incidence 6.2/1,000 PYFU) to support monitoring intensity and avoidance of renal insults 1 [Level I evidence].

Insights & Cautions

Risk depends on age, baseline eGFR, hypertension/diabetes/CVD burden, HCV coinfection, CD4 nadir, and nephrotoxic ART exposure, with higher rates in older, HCV‑coinfected, and CD4‑suppressed patients (D:A:D cohort, 17 954 participants; IRR‑based model) 1. Use cautiously: models underperform in external HIV populations, may misclassify those with AKI, and are sensitive to eGFR variability in Black patients reclassified by race‑free equations 2.